Executives at Johnson & Johnson, the American multinational medical devices and pharmaceutical corporation, knew years before they recalled [the] troubled artificial hip in 2010 that it had a critical design flaw, The New York Times writes, but the company concealed that information from physicians and patients, according to internal documents disclosed on Friday during a trial related to the device’s failure.